BioAge Labs

News
Hand holding a pen following the peaks and troughs of a graph on screen

BioAge's $100m IPO, and other biotech financings

Our round-up of financings in the biotech sector this week is led by BioAge Lab's filing of an initial public offering (IPO), with a placeholder target of $100 million, plus sizeable privat